BSECompany Update1d ago · 23 Oct 2026, 07:44 pm
Recording Link of Analyst call - Q2 Results
Torrent Pharmaceuticals Ltd · 500420
✦ AI SummaryResults
Torrent Pharmaceuticals Ltd has released the audio recording of its conference call with analysts and investors regarding its Q2 results for the quarter and half year ended 30th September, 2026, which can be accessed on the company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
b2310466-892c-4733-b2ad-9ed1dd084cd2.pdf
View document text
23rd October, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited, National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Audio Recording of Conference call with Analysts / Investors on Financial Results for
the quarter and half year ended 30th September, 2026
In continuation of our letter dated 09-Oct-26 and pursuant to Regulation 30(6) of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference
call with Analysts / Investors on Financial Results of the Company for the quarter and half year
ended 30th September, 2026, has been placed on the Company’s website at
https://www.torrentpharma.com/pdf/investors/Audio_Recording30092026.mp3
Thanking you,
Yours Sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com